Zobrazeno 1 - 10
of 495
pro vyhledávání: '"John J. LiPuma"'
Autor:
Stefanie Widder, Lisa A. Carmody, Kristopher Opron, Linda M. Kalikin, Lindsay J. Caverly, John J. LiPuma
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Polymicrobial infection of the airways is a hallmark of obstructive lung diseases such as cystic fibrosis (CF), non-CF bronchiectasis, and chronic obstructive pulmonary disease. Pulmonary exacerbations (PEx) in these conditions are associate
Externí odkaz:
https://doaj.org/article/cf1a281cf36948d7abd6967ae7644c55
Autor:
Stephanie Steyaert, Charlotte Peeters, Anneleen D. Wieme, Astrid Muyldermans, Kristof Vandoorslaer, Theodore Spilker, Ingrid Wybo, Denis Piérard, John J. LiPuma, Peter Vandamme
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 6 (2024)
ABSTRACT A collection of 161 Ralstonia isolates, including 90 isolates from persons with cystic fibrosis, 27 isolates from other human clinical samples, 8 isolates from the hospital environment, 7 isolates from industrial samples, and 19 environmenta
Externí odkaz:
https://doaj.org/article/6825b2a9b461441e85fab48607a06b03
Autor:
Laura J Rojas, Mohamad Yasmin, Jacquelynn Benjamino, Steven M Marshall, Kailynn J DeRonde, Nikhil P Krishnan, Federico Perez, Andrew A Colin, Monica Cardenas, Octavio Martinez, Armando Pérez-Cardona, Daniel D Rhoads, Michael R Jacobs, John J LiPuma, Michael W Konstan, Alejandro J Vila, Andrea Smania, Andrew R Mack, Jacob G Scott, Mark D Adams, Lilian M Abbo, Robert A Bonomo
Publikováno v:
PLoS ONE, Vol 17, Iss 3, p e0265129 (2022)
BackgroundPseudomonas aeruginosa is a persistent and difficult-to-treat pathogen in many patients, especially those with Cystic Fibrosis (CF). Herein, we describe a longitudinal analysis of a series of multidrug resistant (MDR) P. aeruginosa isolates
Externí odkaz:
https://doaj.org/article/b792cfbcd3cf4cadae6ebcb48376470a
Autor:
Erlinda R. Ulloa, Armin Kousha, Hannah Tsunemoto, Joe Pogliano, Carmelo Licitra, John J. LiPuma, George Sakoulas, Victor Nizet, Monika Kumaraswamy, Stijn van der Veen
Publikováno v:
Infectious Microbes & Diseases, Vol 2, Iss 1, Pp 10-17 (2020)
Abstract. Azithromycin (AZM), the most commonly prescribed antibiotic in the United States, is thought to have no activity against multidrug-resistant Gram-negative pathogens such as Achromobacter xylosoxidans (AX) per standard minimum inhibitory con
Externí odkaz:
https://doaj.org/article/e139874f187347c2ba38af81490aca61
Autor:
Kevin R. Barker, Michael Santino, John J. LiPuma, Elizabeth Tullis, Matthew P. Muller, Larissa M. Matukas, Manal Tadros
Publikováno v:
Microbiology Spectrum, Vol 9, Iss 3 (2021)
ABSTRACT The IR Biotyper and matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) using ClinProTools software (MALDI-TOF MS–ClinProTools) are two novel typing methods that rely on the analysis of carbohydrat
Externí odkaz:
https://doaj.org/article/f0a0ea12809045c681129d34eb2d410c
Autor:
George A. O’Toole, Aurélie Crabbé, Rolf Kümmerli, John J. LiPuma, Jennifer M. Bomberger, Jane C. Davies, Dominique Limoli, Vanessa V. Phelan, James B. Bliska, William H. DePas, Lars E. Dietrich, Thomas H. Hampton, Ryan Hunter, Cezar M. Khursigara, Alexa Price-Whelan, Alix Ashare, Robert A. Cramer, Joanna B. Goldberg, Freya Harrison, Deborah A. Hogan, Michael A. Henson, Dean R. Madden, Jared R. Mayers, Carey Nadell, Dianne Newman, Alice Prince, Damian W. Rivett, Joseph D. Schwartzman, Daniel Schultz, Donald C. Sheppard, Alan R. Smyth, Melanie A. Spero, Bruce A. Stanton, Paul E. Turner, Chris van der Gast, Fiona J. Whelan, Rachel Whitaker, Katrine Whiteson
Publikováno v:
mBio, Vol 12, Iss 5 (2021)
A recent workshop titled “Developing Models to Study Polymicrobial Infections,” sponsored by the Dartmouth Cystic Fibrosis Center (DartCF), explored the development of new models to study the polymicrobial infections associated with the airways o
Externí odkaz:
https://doaj.org/article/1ed07d7593e74bbf8897df772ce78eb2
Publikováno v:
ERJ Open Research, Vol 7, Iss 4 (2021)
Externí odkaz:
https://doaj.org/article/46f459501d814f3ba39a16b2d5a62083
Cystic fibrosis airway microbiota associated with outcomes of nontuberculous mycobacterial infection
Publikováno v:
ERJ Open Research, Vol 7, Iss 2 (2021)
Rationale Pulmonary infections with nontuberculous mycobacteria (NTM) are increasingly prevalent in people with cystic fibrosis (CF). Clinical outcomes following NTM acquisition are highly variable, ranging from transient self-resolving infection to
Externí odkaz:
https://doaj.org/article/8cc33c2b8d8948e2915501b74e5e06d4
Publikováno v:
Antibiotics, Vol 11, Iss 5, p 674 (2022)
Tebipenem-pivoxil hydrobromide, an orally bioavailable carbapenem, is currently in clinical development for the treatment of extended-spectrum β-lactamase- and AmpC-producing Enterobacterales. Previously, tebipenem was found to possess antimicrobial
Externí odkaz:
https://doaj.org/article/879e434382564d9b91c4a95facdea8ca
Autor:
Junnan Lu, Lisa A. Carmody, Kristopher Opron, Richard H. Simon, Linda M. Kalikin, Lindsay J. Caverly, John J. LiPuma
Publikováno v:
mSystems, Vol 5, Iss 4 (2020)
ABSTRACT Culture-independent studies of the cystic fibrosis (CF) airway microbiome typically rely on expectorated sputum to assess the microbial makeup of lower airways. These studies have revealed rich bacterial communities. There is often considera
Externí odkaz:
https://doaj.org/article/355f68c95bc04125be252eb4d70f1c3d